Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of “Hold” by Analysts
01:29am, Thursday, 29'th Jan 2026
NeoGenomics, Inc. (NASDAQ: NEO - Get Free Report) has received a consensus recommendation of "Hold" from the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One e
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
07:05am, Tuesday, 27'th Jan 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its fourth quarter and full year 2025 financial results prior to the open of the U.S. financial markets on Feb. 17, 2026.
NeoGenomics: Distribution Moat In Community Oncology
05:17am, Sunday, 25'th Jan 2026
NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform, leveraging deep relationships with community oncologists. NEO's clinical services reve
Campbell & CO Investment Adviser LLC Has $235,000 Stock Holdings in NeoGenomics, Inc. $NEO
03:44am, Sunday, 25'th Jan 2026
Campbell and CO Investment Adviser LLC lowered its position in NeoGenomics, Inc. (NASDAQ: NEO) by 60.3% in the third quarter, according to the company in its most recent 13F filing with the Securities
NEW YORK--(BUSINESS WIRE)---- $BETR #AI--Better Home & Finance Holding Company (NASDAQ: BETR) (“Better.com”), the leading AI-native home finance company and the first fintech to fund more than $10
Comparing AstraZeneca (NASDAQ:AZN) and NeoGenomics (NASDAQ:NEO)
02:16am, Monday, 19'th Jan 2026
NeoGenomics (NASDAQ: NEO - Get Free Report) and AstraZeneca (NASDAQ: AZN - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based o
NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
12:06am, Wednesday, 14'th Jan 2026
NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AerCap Signs Purchase and Leaseback Agreements with Virgin Atlantic for Six New Airbus A330NEO Aircraft
07:00am, Tuesday, 13'th Jan 2026
DUBLIN, Jan. 13, 2026 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) today announced it has signed purchase and leaseback agreements with Virgin Atlantic for six new Airb
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
07:05am, Monday, 12'th Jan 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced preliminary fourth quarter and full-year 2025 revenue and also announced a transition of the Company's Chief Financial Officer.
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
07:05am, Monday, 05'th Jan 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
07:05am, Tuesday, 30'th Dec 2025
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of John P. “Jack” Kenny to its Board of Directors.
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
07:05am, Monday, 15'th Dec 2025
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation.
NeoGenomics to Present New ctDNA Research at SABCS 2025
07:05am, Wednesday, 10'th Dec 2025
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present data on its RaDaR 1.0 assay for molecular residual disease detection at the 2025 San Antonio Breast Cancer Symposium.
AerCap Signs Lease Agreements with New Customer My Freighter for Two New Airbus A321NEO Aircraft
04:00am, Tuesday, 09'th Dec 2025
DUBLIN , Dec. 9, 2025 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) today announced it has signed lease agreements for two new Airbus A321neo aircraft with My Freighter
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
08:05am, Monday, 08'th Dec 2025
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in myeloid malignancies.
